Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups

Nature Communications

Volumn 4, Issue , 2013, Pages

  Maitra, Arindam ^a   Biswas, Nidhan K ^a   Amin, Kishore ^b   Kowtal, Pradnya ^b   Kumar, Shantanu ^a   Das, Subrata ^a   Sarin, Rajiv ^b   Majumder, Partha P ^a   Bagchi, I ^a   Bairagya, B B ^a   Basu, A ^a   Bhan, M K ^c   Chaturvedi, P ^b   Das, D ^a   D'Cruz, A ^b   Dhar, R ^a   Dutta, D ^a   Ganguli, D ^a   Gera, P ^b   Gupta, T ^b   Mahapatra, S ^a   Mujawar, M H K ^a   Mukherjee, S ^a   Nair, S ^b   Nikam, S ^b   Nobre, M ^b   Patil, A ^b   Patra, S ^a   Rama Gowtham, M ^a   Rao, T S ^c   Roy, B ^a   Roychowdhury, B ^a   Sarkar, D ^d   Sarkar, S ^a   Sarkar Roy, N ^a   Sutradhar, D ^a   more..

^a NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS   (India)

^b TATA MEMORIAL HOSPITAL   (India)

^c Department of Biotechnology CGO Complex ^*  (India)

^d INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH1 RECEPTOR; PROTEIN P53; TRANSCRIPTION FACTOR YAP1; UNTRANSLATED RNA;

ANATOMY; CANCER; DISEASE INCIDENCE; GENE EXPRESSION; MOLECULAR ANALYSIS; MUTATION; SURVIVAL; TOBACCO;

ADULT; ARTICLE; CANCER RECURRENCE; CHROMOSOME 11Q; CLINICAL ARTICLE; COPY NUMBER VARIATION; DISEASE FREE SURVIVAL; DNA MICROARRAY; EXOME; EXON; FEMALE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GINGIVO BUCCAL ORAL SQUAMOUS CELL CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HERPES SIMPLEX; HUMAN; HUMAN TISSUE; MALE; MOUTH SQUAMOUS CELL CARCINOMA; MUTATION RATE; PAPILLOMAVIRUS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; SMOKING; SOMATIC MUTATION;

NICOTIANA TABACUM;

ADULT; CADHERINS; CARCINOMA, SQUAMOUS CELL; CASPASE 8; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84890177607     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3873     Document Type: Article

References (69)

1. World Health Organization. Strengthening the prevention of oral cancer: the WHO perspective http://www.who.int/oral-health/publications/ CDOE05-vol33-397-9/en/(accessed on 26 Oct 2013).
2. Dikshit, R. et al. Cancer mortality in India: a nationally representative survey. Lancet 379, 1807-1816 (2012).
3. International Agency for Research on Cancer. GLOBOCAN 2008. http:// globocan.iarc.fr/factsheets/populations/factsheet.asp?uno=900 (accessed on 26 Oct 2013).
4. World Health Organization. Tobacco free initiative http://www.who.int/ tobacco/research/cancer/en/(accessed on 26 Oct 2013).
5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Betel-quid and areca-nut chewing and some areca-nut-derived nitrosamines. IARC monographs on the evaluation of carcinogenic risks to humans v. 85Lyon, France, 2003 (http://monographs.iarc.fr/ENG/Monographs/vol85/mono85.pdf) accessed 2013.
6. Boffetta, P., Hecht, S., Gray, N., Gupta, P. & Strad, K. Smokeless tobacco and cancer. Lancet Oncol. 9, 667-675 (2008). (Pubitemid 351878052)
7. Gupta, P. C., Ray, C. S., Sinha, D. N. & Singh, P. K. Smokeless tobacco: a major public health problem in the SEA region: A review. Ind. J. Pub. Health 55, 199-209 (2011).
8. Chocolatewala, N. M. & Chaturvedi, P. Role of human papilloma virus in the oral carcinogenesis: an Indian perspective. J. Can. Res. Ther. 5, 71-77 (2009).
9. Khan, Z. An overview of oral cancer in indian subcontinent and recommendations to decrease its incidence. WebmedCentral Cancer 3, WMC003626 (2012) http://www.webmedcentral.com/article-view/3626 (accessed August 2013).
10. Warnakulasuriya, S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45, 309-316 (2009).
11. Walvekar, R. R. Squamous cell carcinoma of the gingivobuccal complex: predictors of locoregional failure in stage III-IV cancers. Oral. Oncol. 45, 135-140 (2009).
12. Agrawal, N. et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333, 1154-1157 (2011).
13. Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157-1160 (2011).
14. Pickering, C. R. et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 3, 770-781 (2013).
15. Fanjul-Fernández, M. et al. Cell-cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinoma. Nat. Commun. 4, 2531 (2013).
16. Shukla, S. et al. Immunoproteomics reveals that cancer of the tongue and the gingivobuccal complex exhibit differential autoantibody response. Cancer Biomark. 5, 127-135 (2009).
17. Sun, S., Schiller, J. H. & Gazdar, A. F. Lung cancer in never smokers-a different disease. Nat. Rev. Cancer 7, 778-790 (2007). (Pubitemid 47463669)
18. Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226-231 (2012).
19. Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993 (2012).
20. Kino, K. & Sugiyama, H. GC-CG transversion mutation might be caused by 8-oxoguanine oxidation product. Nucleic Acids Symp. Ser. 44, 139-140 (2000).
21. Paz-Elizur, T. et al. DNA repair activity for oxidative damage and risk of lung cancer. J. Natl Cancer Inst. 95, 1312-1319 (2003). (Pubitemid 37160864)
22. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013).
23. Dees, N. D. et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 22, 1589-1598 (2012).
24. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
25. Leemans, C. R., Braakhuis, B. J. M. & Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9-22 (2011).
26. Agrawal, P., Chen, Y. T., Schilling, B., Gibson, B. W. & Hughes, R. E. Ubiquitinspecific peptidase 9, X-linked (USP9X) modulates activity of mammalian target of rapamycin (mTOR). J Biol Chem. 287, 21164-21175 (2012).
27. Pérez-Mancera, P. A. et al. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486, 266-270 (2012).
28. Cho, Y. W. et al. PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J. Biol. Chem. 282, 20395-20406 (2007).
29. Ansari, K. I., Hussain, I., Das, H. K. & Mandal, S. S. Overexpression of human histone methylase MLL1 upon exposure to a food contaminant mycotoxin, deoxynivalenol. FEBS J. 276, 299-307 (2009).
30. Biankin, A. V. et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399-405 (2012).
31. Shain, A. H. & Pollack, J. R. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PLoS One 8, e55119 (2013).
32. Ariel, P. & Ryan, T. A. New insights into molecular players involved in neurotransmitter release. Physiology 27, 15-24 (2012).
33. Zamudio-Bulcock, P. A., Everett, J., Harteneck, C. & Valenzuela, C. F. Activation of steroid-sensitive TRPM3 channels potentiates glutamatergic transmission at cerebellar Purkinje neurons from developing rats. J. Neurochem. 119, 474-485 (2011).
34. Ying, Z. et al. Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res. 73, 990-999 (2013).
35. Olivier, M., Hollstein, M. & Hainaut, P. TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2, a001008 (2010).
36. Williams, S. E., Beronja, S., Pasolli, H. A. & Fuchs, E. Asymmetric cell divisions promote Notch-dependent epidermal differentiation. Nature 470, 353-358 (2011).
37. Brumbaugh, K. M. et al. The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells. Mol. Cell 4, 585-598 (2004). (Pubitemid 38739082)
38. Callender, T. et al. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74, 152-158 (1994). (Pubitemid 24187623)
39. Toomes, C. et al. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer 37, 132-140 (2003). (Pubitemid 36529780)
40. Farrell, C. et al. Somatic mutations to CSMD1 in colorectal adenocarcinomas. Cancer Biol. Ther. 7, 609-613 (2008). (Pubitemid 351847040)
41. Ward, Jr J. H. Hierarchical grouping to optimize an objective function. J. Am. Stat. Assoc. 58, 236-244 (1963).
42. Morris, L. G. et al. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nat. Genet. 45, 253-261 (2013).
43. Qi, C., Zhu, Y. T., Hu, L. & Zhu, Y.-J. Identification of Fat4 as a candidate tumor suppressor gene in breast cancers. Int. J. Cancer 124, 793-798 (2009).
44. Bornstein, S. et al. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J. Clin. Invest. 119, 3408-3419 (2009).
45. Dupont, S. et al. FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 136, 123-135 (2009).
46. Li, M. et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat. Genet. 43, 828-829 (2011).
47. Manceau, G. et al. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma. Int. J. Cancer 132, 2217-2221 (2013).
48. Sausen, M. et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat. Genet. 45, 12-17 (2013).
49. McGehee, D. S., Heath, M. J., Gelber, S., Devay, P. & Role, L. W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269, 1692-1696 (1995).
50. Choi, Y., Sims, G. E., Murphy, S., Miller, J. R. & Chan, A. P. Predicting the functional effect of amino acid substitutions and indels. PLoS One 7e46688 (2012).
51. Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081 (2009).
52. Saranath, D. et al. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br. J. Cancer 63, 573-578 (1991).
53. Fernández-Medarde, A. & Santos, E. Ras in Cancer and Developmental Diseases. Genes Cancer 2, 344-358 (2012).
54. Robinson, G. et al. Novel mutations target distinct subgroups of medulloblastoma. Nature 488, 43-48 (2012).
55. Wieser, R. The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Gene 396, 346-357 (2007). (Pubitemid 46935408)
56. Bell, D. et al. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
57. Dedes, K. J. et al. Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur. J. Cancer 47, 138-150 (2011).
58. Dooley, A. L. et al. Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev. 25, 1470-1475 (2011).
59. Moon, H. G. et al. NFIB is a potential target for estrogen receptor-negative breast cancers. Mol. Oncol. 5, 538-544 (2011).
60. Knights, V. & Cook, S. J. De-regulated FGF receptors as therapeutic targets in cancer. Pharmacol Ther. 125, 105-117 (2010).
61. Zhao, G. et al. A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft models. Mol. Cancer Ther. 10, 2200-2210 (2011).
62. Lilly. Lilly oncology pipeline: FGFR inhibitor. Eli Lilly and Company 2012 Annual Report, page 10 http://www.lillyoncologypipeline. com/Pages/fgfr-inhibitor.aspx (accessed on 26 Oct 2013).
63. Eng, H. L., Lin, T. M., Chen, S. Y., Wu, S. M. & Chen, W. J. Failure to detect human papillomavirus DNA in malignant epithelial neoplasms of conjunctiva by polymerase chain reaction. Am. J. Clin. Pathol. 117, 429-436 (2002).
64. Babraham Bioinformatics. FastQC http://www.bioinformatics.babraham.ac.uk/ projects/fastqc/fastqc-v0.10.1.zip (accessed on 26 Oct 2013).
65. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler Transform. Bioinformatics 25, 1754-1760 (2009).
66. 1000genomes ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/reference/ phase2-reference-assembly-sequence/ (accessed on 26 Oct 2013).
67. Li, H. et al. The Sequence alignment/map (SAM) format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
68. DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498 (2011).
69. van Loo et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910-16915 (2010).